•
Nov 1, 2024
Oct 31, 2024
Nov 2, 2024
Oct 30, 2024
Oct 25, 2024
Gain Therapeutics, Inc. [GANX] has reported fiscal Q1 loss of $5.10 million.
On a per-share basis, the DE based company said its diluted earnings are $0.43.
The Pharmaceutical Preparations firm posted revenue of $55.20 million in this period.